<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Supervised dosing with a long‐acting opioid medication in the management of opioid dependence - Saulle, R - 2017 | Cochrane Library</title> <meta content="Supervised dosing with a long‐acting opioid medication in the management of opioid dependence - Saulle, R - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011983.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Supervised dosing with a long‐acting opioid medication in the management of opioid dependence - Saulle, R - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011983.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011983.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Supervised dosing with a long‐acting opioid medication in the management of opioid dependence" name="citation_title"/> <meta content="Rosella Saulle" name="citation_author"/> <meta content="Lazio Regional Health Service" name="citation_author_institution"/> <meta content="Simona Vecchi" name="citation_author"/> <meta content="Lazio Regional Health Service" name="citation_author_institution"/> <meta content="s.vecchi@deplazio.it" name="citation_author_email"/> <meta content="Linda Gowing" name="citation_author"/> <meta content="University of Adelaide" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD011983.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/04/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011983.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011983.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011983.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Analgesics, Opioid [adverse effects, *therapeutic use]; Buprenorphine, Naloxone Drug Combination [adverse effects, *therapeutic use]; Directly Observed Therapy [adverse effects, *methods]; Methadone [adverse effects, *therapeutic use]; Observational Studies as Topic; Opiate Substitution Treatment [adverse effects, *methods]; Opioid‐Related Disorders [*drug therapy]; Prescription Drug Diversion [statistics &amp; numerical data]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011983.pub2&amp;doi=10.1002/14651858.CD011983.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011983\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011983\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","hr","fr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011983.pub2",title:"Supervised dosing with a long\\u2010acting opioid medication in the management of opioid dependence",firstPublishedDate:"Apr 27, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Drugs and Alcohol Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011983.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011983.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011983.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011983.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011983.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011983.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011983.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011983.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011983.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011983.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5720 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011983.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0108"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-sec-0102"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/appendices#CD011983-sec-0113"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/table_n/CD011983StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/table_n/CD011983StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Supervised dosing with a long‐acting opioid medication in the management of opioid dependence </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information#CD011983-cr-0002">Rosella Saulle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information#CD011983-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Simona Vecchi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information#CD011983-cr-0004">Linda Gowing</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information/en#CD011983-sec-0120">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 April 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011983.pub2">https://doi.org/10.1002/14651858.CD011983.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011983-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011983-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011983-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011983-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011983-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011983-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011983-abs-0001" lang="en"> <section id="CD011983-sec-0001"> <h3 class="title" id="CD011983-sec-0001">Background</h3> <p>Opioid dependence (OD) is an increasing clinical and public health problem worldwide. International guidelines recommend opioid substitution treatment (OST), such as methadone and buprenorphine, as first‐line medication treatment for OD. A negative aspect of OST is that the medication used can be diverted both through sale on the black market, and the unsanctioned use of medications. Daily supervised administration of medications used in OST has the advantage of reducing the risk of diversion, and may promote therapeutic engagement, potentially enhancing the psychosocial aspect of OST, but costs more and is more restrictive on the client than dispensing for off‐site consumption. </p> </section> <section id="CD011983-sec-0002"> <h3 class="title" id="CD011983-sec-0002">Objectives</h3> <p>The objective of this systematic review is to compare the effectiveness of OST with supervised dosing relative to dispensing of medication for off‐site consumption. </p> </section> <section id="CD011983-sec-0003"> <h3 class="title" id="CD011983-sec-0003">Search methods</h3> <p>We searched in Cochrane Drugs and Alcohol Group Specialised Register and Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, Web of Science from inception up to April 2016. Ongoing and unpublished studies were searched via ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (http://www.who.int/ictrp/en/). </p> <p>All searches included non‐English language literature. We handsearched references on topic‐related systematic reviews. </p> </section> <section id="CD011983-sec-0004"> <h3 class="title" id="CD011983-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs), controlled clinical trials (CCTs), and prospective controlled cohort studies, involving people who are receiving OST (methadone, buprenorphine) and comparing supervised dosing with dispensing of medication to be consumed away from the dispensing point, usually without supervision. </p> </section> <section id="CD011983-sec-0005"> <h3 class="title" id="CD011983-sec-0005">Data collection and analysis</h3> <p>We used the standard methodological procedures expected by Cochrane.</p> </section> <section id="CD011983-sec-0006"> <h3 class="title" id="CD011983-sec-0006">Main results</h3> <p>Six studies (four RCTs and two prospective observational cohort studies), involving 7999 participants comparing supervised OST treatment with unsupervised treatment, met the inclusion criteria. The risk of bias was generally moderate across trials, but the results reported on outcomes that we planned to consider were limited. Overall, we judged the quality of the evidence from very low to low for all the outcomes. </p> <p>We found no difference in retention at any duration with supervised compared to unsupervised dosing (RR 0.99, 95% CI 0.88 to 1.12, 716 participants, four trials, <i>low‐quality evidence</i> ) or in retention in the shortest follow‐up period, three months (RR 0.94; 95% CI 0.84 to 1.05; 472 participants, three trials, <i>low‐quality evidence</i> ). Additional data at 12 months from one observational study found no difference in retention between groups (RR 0.94, 95% CI 0.77 to 1.14; n = 300).There was no difference in abstinence at the end of treatment (self‐reported drug use) (67% versus 60%, P = 0.33, 293 participants, one trial, <i>very low‐quality evidence</i> ); and in diversion of medication (5% versus 2%, 293 participants, one trial, <i>very low‐quality evidence</i>). </p> <p>Regarding our secondary outcomes, we did not found a difference in the incidence of adverse effects in the supervised compared to unsupervised control group (RR 0.63; 96% CI 0.10 to 3.86; 363 participants, two trials, <i>very low‐quality evidence</i> ). Data on severity of dependence were very limited (244 participants, one trial) and showed no difference between the two approaches. Data on deaths were reported in two studies. One trial reported two deaths in the supervised group (<i>low‐quality evidence</i>), while in the cohort study all‐cause mortality was found lower in regular supervision group (crude mortality rate 0.60 versus 0.81 per 100 person‐years), although after adjustment insufficient evidence existed to suggest that regular supervision was protective (mortality rate ratio = 1.23, 95% CI = 0.67 to 2.27). </p> <p>No studies reported pain symptoms, drug craving, aberrant opioid‐related behaviours, days of unsanctioned opioid use and overdose. </p> </section> <section id="CD011983-sec-0007"> <h3 class="title" id="CD011983-sec-0007">Authors' conclusions</h3> <p>Take‐home medication strategies are attractive to treatment services due to lower costs, and place less restrictions on clients, but it is unknown whether they may be associated with increased risk of diversion and unsanctioned use of medication. There is uncertainty about the effects of supervised dosing compared with unsupervised medication due to the low and very low quality of the evidence for the primary outcomes of interest for this review. Data on defined secondary outcomes were similarly limited. More research comparing supervised and take‐home medication strategies is needed to support decisions on the relative effectiveness of these strategies. The trials should be designed and conducted with high quality and over a longer follow‐up period to support comparison of strategies at different stages of treatment. In particular, there is a need for studies assessing in more detail the risk of diversion and safety outcomes of using supervised OST to manage opioid dependence. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011983-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011983-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011983-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011983-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011983-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011983-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011983-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011983-abs-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011983-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011983-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011983-abs-0005" lang="en"> <h3>Supervised‐dosing strategies versus take‐home opioid substitution treatment for people dependent on opioid drugs </h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the effectiveness of supervised dosing strategies in opioid substitution treatment for people dependent on opioid drugs. </p> <p><b>Background</b> </p> <p>Opioid dependence (OD) is a global clinical and public health problem that is associated with significant burden of disease and drug‐related deaths. OD represents a complex health condition that usually requires long‐term treatment. International guidelines recommend opioid substitution treatment (OST), such as methadone and buprenorphine, as a first‐line treatment for OD. OST is a form of health care for people who are dependent on heroin, or who have become dependent after taking prescribed opioids for pain, and involves substitution of the drug that is being used inappropriately with a long‐acting opioid. OST gives people who are opioid dependent the opportunity to stabilise their lives, and to address the social and psychological dimensions that tend to accompany opioid dependence. A negative aspect of OST is that the medications used can be diverted, by being sold on the black market or used inappropriately. One strategy for minimising diversion is for OST medications to be administered under supervision (supervised dosing). With supervised dosing, access to unsupervised or take‐away doses of medication is then a privilege which can be used as a motivational and reward incentive. Supervised dosing is also associated with more frequent contact between the client and service provider offering more opportunities for therapeutic engagement. However, providing supervised dosing is more expensive for service providers, and more restrictive for clients who have to attend for dosing every day. The purpose of this review was to assess the effectiveness of supervised dosing, compared to dispensing of take‐home medication, in terms of reduction in heroin and other unsanctioned opioid use, retention in treatment, diversion of medication and adverse effects. </p> <p><b>Search date</b> </p> <p>The evidence is current to April 2016.</p> <p><b>Study characteristics</b> </p> <p>We identified six studies involving 7999 people receiving treatment with methadone (7786 people) or buprenorphine–naloxone (213 people ) for opioid dependence. Four of the studies were randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups), while the other two studies followed groups of people over time. Four of the studies were funded by the National Institutes for Health Research and by the Health Research Board, with one study not reporting the funding source. One study was also funded by the drug company of buprenorphine–naloxone. </p> <p><b>Key results</b> </p> <p>At three or more months follow‐up, this review found no evidence on benefit of the supervised dosing with respect to keep people in treatment, or reduce opioid use, mortality reduction and adverse drug events. One study found that supervised dosing led to a reduction of diversion. None of the studies assessed the effect of supervised dosing on pain symptoms, drug craving, days of unsanctioned opioid use, overdose and hospitalisation. </p> <p>We are unable to make any conclusion about the effectiveness of supervised dosing compared to dispensing of medication as take‐home doses, in the context of OST. Further research is required to determine the effectiveness of supervised or take‐home dosing in OST. </p> <p><b>Quality of the evidence</b> </p> <p>Overall, the studies were moderately well‐conducted, but there was a small number of studies reporting outcomes of interest, therefore insufficient to evaluate the efficacy of intervention such as diversion, opoid use reduction, retention in treatment and frequency of unsanctioned opioid use, Furthermore, low rates of occurrence of some events between studies resulted in the overall quality of the evidence being assessed as low and very low. This indicates that further evidence would be likely to change the estimates of relative effect made in this review. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011983-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011983-sec-0108"></div> <h3 class="title" id="CD011983-sec-0109">Implications for practice</h3> <section id="CD011983-sec-0109"> <p>Evidence on the use of supervised dosing in the context of opioid substitution treatment (OST) for the management of opioid dependence was limited to six studies, some of them we considered at high risk of bias. At present, there is uncertainty about the effects of supervised dosing compared unsupervised medication due to the low and very low quality of the evidence. For opioid‐dependent people receiving OST, the decision to use supervised OST versus unsupervised treatment should be made on a case‐by‐case basis, taking into account the characteristics of patients, and social factors (i.e. employment status and social relationships). </p> </section> <h3 class="title" id="CD011983-sec-0110">Implications for research</h3> <section id="CD011983-sec-0110"> <p>More randomised trials with larger samples sizes are still needed to further explore the current available evidence for supervised or take‐home strategies for the management of opioid dependence in long‐acting opioid medication. </p> <p>The efficacy of the intervention needs further exploration of replication and applicability to other settings and extended population (i.e. of heroin dependents as well as of prescription‐opioid dependents). Future high‐quality trials should designed and conducted and address long‐term outcomes to further investigate delayed effects of OST. In particular, there is a need for studies assessing in more detail the risk of diversion and safety outcomes of using supervised OST to manage opioid dependence. </p> <p>At present, the results of our review do not allow us to answer the most relevant clinical question, that is which is the most effective type of treatment in terms of supervised or take‐away dosing? </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011983-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011983-sec-0036"></div> <div class="table" id="CD011983-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supervised dosing with a long‐acting medication compared to unsupervised consumption for opioid dependence</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Supervised versus unsupervised dosing</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with opioid dependence<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> supervised dosing with a long‐acting medication<br/> <b>Comparison:</b> unsupervised consumption </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Unsupervised</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Supervised</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Retention ‐ retention at the end of treatment</b> <br/> (number of participants)<br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.99</b> <br/> (0.88 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>716<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>634 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>628 per 1000</b> <br/> (558 to 710) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>653 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>646 per 1000</b> <br/> (575 to 731) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Retention ‐ retention at 3 months</b> <br/> (number of participants)<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.94</b> <br/> (0.84 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>472<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>707 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>664 per 1000</b> <br/> (594 to 742) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>737 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>693 per 1000</b> <br/> (619 to 774) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse serious events (any)</b> <br/> (number of participants)<br/> Follow‐up: mean 7.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.63</b> <br/> (0.10 to 3.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>363<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> <br/> (8 to 298) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (8 to 309) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Abstinence from unsanctioned opioid use</b> <br/> (number of participants with urine drug screen or self‐report use)<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>293<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>No difference between supervised and no supervised therapy in self‐reported heroin use at 3 months (67% <i>vs</i> 60%, P = 0.33) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Diversion (</b>number of participants)<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>293<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5% respondents in the supervised group and 2% in the unsupervised group reported that "they had let another person have their drug", but it is not clear if the data referred to diversion. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of unsanctioned opioid use at the end of the intervention (number of days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality ‐</b> <br/> (number of participants) </p> <p>Follow‐up: mean 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>230<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It was reported one death from gastric haemorrhage at day 304 post‐enrolment, and one death from pneumonia at day 334 post‐enrolment. </p> <p>In one cohort study (6983 participants), the mortality rate ratio was unrelated to regular supervised methadone consumption. All‐cause mortality was lower in those with regular supervision (crude mortality rate 0.60 versus 0.81 per 100 person‐years), although after adjustment insufficient evidence existed to suggest that regular supervision was protective (mortality rate ratio = 1.23, 95% CI = 0.67–2.27). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded of two levels because all studies were at high risk for performance bias, one at high risk of detection bias and one at unclear risk for selection bias<br/> <sup>2</sup> Downgraded of two levels because all studies were at high risk for performance bias, one at high risk of detection bias and one at unclear risk for selection bias<br/> <sup>3</sup> Downgraded of two levels because two studies at high risk for performance and detection bias<br/> <sup>4</sup> Downgraded of two levels because OIS not met<br/> <sup>5</sup> Downgraded of two levels because the study was at high risk for performance and detection bias </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011983-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011983-sec-0037"></div> <section id="CD011983-sec-0038"> <h3 class="title" id="CD011983-sec-0038">Description of the condition</h3> <p>Past‐year global use of opioids, including heroin and prescription painkillers, is estimated at between 28.6 million and 38 million (<a href="./references#CD011983-bbs2-0054" title="United Nations Office on Drugs and Crime. World Drug Report 2016. United Nations publication2016. ">UNODC 2016</a>). In 2014, 4.3 million people aged 12 or older reported current non‐medical use of prescription pain relievers and, in the same year, about 435,000 people aged 12 or older were current heroin users (<a href="./references#CD011983-bbs2-0049" title="SAMHSA2015 . Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS Publication No. SMA 15‐4927, NSDUH Series H‐50. Accessed January 2016. ">SAMSHA 2015 b</a>). The need to improve access to pain relief has influenced this rise: more than 100 million people suffer from chronic pain in the USA alone (<a href="./references#CD011983-bbs2-0034" title="Institute of Medicine 2011. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The National Academies Press. Washington: Ebook: 978‐0‐309‐21488‐9, 2011. [DOI: 10.17226/13172] ">IOM 2011</a>; <a href="./references#CD011983-bbs2-0035" title="JohannesCB , LeTK , ZhouX , JohnstonJA , DworkinRH . The prevalence of chronic pain in United States adults: results of an Internet‐based survey. Journal of Pain2010;11(11):1230‐9. [DOI: 10.1016/j.jpain.2010.07.002.] ">Johannes 2010</a>), and in this context prescription opioids provide a therapeutic value for the management of pain relief and palliative care (<a href="./references#CD011983-bbs2-0031" title="FranklinGM , RahmanEA , TurnerJA , DaniellWE , Fulton‐KehoeD . Opioid use for chronic low back pain: A prospective, population‐based study among injured workers in Washington state, 2002‐2005. Clinical Journal of Pain2009;25(9):743–51. ">Franklin 2009</a>). </p> <p>But in recent times prescription opioids have been increasingly used to treat chronic non‐cancer pain (<a href="./references#CD011983-bbs2-0036" title="KissinI . Long‐term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?. Journal of Pain Research2013;6:513‐29. [10.2147/JPR.S47182. Print 2013.] ">Kissin 2013</a>). The number of prescription opioids, such as hydrocodone and oxycodone products that are mostly prescribed for the treatment of moderate‐to‐severe pain have escalated from around 76 million in 1991 to nearly 207 million in 2013, with the USA their biggest consumer globally (<a href="./references#CD011983-bbs2-0053" title="United Nations Office on Drugs and Crime (UNODC). World Drug Report 2015. www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf. ">UNODC 2014</a>). A similar increase has been noted in Canada, where opioid consumption doubled between 2001 and 2009 (<a href="./references#CD011983-bbs2-0029" title="FischerB , ArgentoE . Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician2012;5:ES191–203. ">Fischer 2012</a>). This trend has affected European countries to a lesser extent, although reports from the UK, Germany and Norway also identified an increase in the use of opioid analgesics (<a href="./references#CD011983-bbs2-0050" title="SchubertI , IhleP , SabatowskiR . Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Deutsches Ärzteblatt International2013;110(4):45‐51. [DOI: 10.3238/arztebl.2013.0045.] ">Schubert 2013</a>; <a href="./references#CD011983-bbs2-0058" title="ZinCS , ChenLC , KnaggsRD . Changes in trends and pattern of strong opioid prescribing in primary care. European Journal of Pain (London, England)2014;18(9):1343‐51. [DOI: 10.1002/j.1532‐2149.2014.496.x.] ">Zin 2014</a>). Prescription opioid use has also risen in Australia, with a reported 150% increase in oxycodone prescriptions between 2002 and 2008 (<a href="./references#CD011983-bbs2-0046" title="RoxburghA , BrunoR , LaranceB , BurnsL . Prescription of opioid analgesics and related harms in Australia. Medical Journal of Australia2011;195(5):280‐4. ">Roxburgh 2011</a>). Also, it is recognised that in numerous street‐drug populations in both the USA and Canada, prescription opioids have replaced heroin as the main opioid of choice (<a href="./references#CD011983-bbs2-0029" title="FischerB , ArgentoE . Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician2012;5:ES191–203. ">Fischer 2012</a>; <a href="./references#CD011983-bbs2-0052" title="SigmonS . Characterizing the emerging population of prescription opioid abusers. American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions2006;15:208–12. ">Sigmon 2006</a>). </p> <p>The health consequences associated with the rapid rise in prescription opioids worldwide have been an increase in misuse and addiction (<a href="./references#CD011983-bbs2-0039" title="MaxwellJC . The prescription drug epidemic in the United States: A perfect storm. Drug and Alcohol Review2011;30(3):264‐70. ">Maxwell 2011</a>), in inpatient hospitalisations (<a href="./references#CD011983-bbs2-0038" title="LingW , MooneyL , HillhouseM . Prescription opioid abuse, pain and addiction: Clinical issues and implications. Drug and Alcohol Review2011;30(3):300‐5. ">Ling 2011</a>), emergency department visits (<a href="./references#CD011983-bbs2-0023" title="CaiR , Crane , E , Poneleit , K , PaulozzIL . Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004‐2008. Journal of Pain &amp; Palliative Care Pharmacotherapy2010;24(3):293‐7. ">Cai 2010</a>; <a href="./references#CD011983-bbs2-0048" title="Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug‐Related Emergency Department Visits. Accessed December 10, 2015. Available from: https://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127‐DAWN‐highlights.htm accessed December 10, 2015. ">SAMHSA 2015 a</a>), and overdose. In the USA, rates of opioid overdose deaths increased significantly from 7.9 per 100.000 in 2013 to 9.0 per 100.000 in 2014, with an increase of 14%; over half of those deaths were from prescription opioids (<a href="./references#CD011983-bbs2-0047" title="RuddRA , AleshireN , ZibbellJE , GladdenM . Increases in Drug and Opioid Overdose Deaths‐‐United States, 2000‐2014. MMWR. Morbidity and Mortality Weekly Report2016;64((50‐51)):1378‐82. ">Rudd 2016</a>). </p> </section> <section id="CD011983-sec-0039"> <h3 class="title" id="CD011983-sec-0039">Description of the intervention</h3> <p>Opioid dependence (OD) represents a complex health condition that usually requires long‐term treatment if sustained recovery is to be achieved. The management of OD is similar to other chronic, relapsing medical conditions such as asthma, hypertension and diabetes (<a href="./references#CD011983-bbs2-0040" title="McLellanAT , LewisDC , O’BrienCP , KleberHD . Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA2000;284(13):1689‐9. ">McLellan 2000</a>; <a href="./references#CD011983-bbs2-0056" title="World Health Organization. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention, 2004. WHO/UNODC/UNAIDS position paper2004. ">WHO 2004</a>). International guidelines recommend opioid substitution treatment (OST), such as methadone and buprenorphine, as a first‐line approach in the pharmacologic treatment for OD (<a href="./references#CD011983-bbs2-0042" title="NICE . Technology appraisal guidance‐Methadone and buprenorphine for the management of opioid dependence 2007. https://www.nice.org.uk/guidance/ta114. ">NICE 2007</a>; <a href="./references#CD011983-bbs2-0057" title="WHO2009 . Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. http://www.who.int/hiv/pub/idu/opioid/en/2009; Vol. ISBN 978 92 4 154754 3. ">WHO 2009</a>), whether OD arises from the misuse of heroin or prescribed opioid medications. OST involves the administration of a long‐acting opioid (methadone or buprenorphine) in conjunction with psychosocial support. Long‐term substitution treatment has better outcomes than medically‐supervised detoxification, and should be considered within the context of a harm‐reduction approach. There is strong evidence that OST is more effective than detoxification or drug‐free counselling in terms of retention in treatment, reduction in unsanctioned opioid use, reduction in injecting use, and mortality (<a href="./references#CD011983-bbs2-0027" title="DolanK , MehrjerdiZA . Medication assisted treatment of opioid dependence: a review of the evidence. Australian National Council on Drugs2015. ">Dolan 2015</a>). OST gives people who are opioid dependent the opportunity to stabilise their lives, to address the social and psychological dimensions that tend to accompany OD. It is not just about prescription of medication, but also the psychosocial support and interventions that are an integral part of OST. The physical adaptation to opioid drugs can be addressed later, when they feel more confident in their ability to become and remain abstinent (<a href="./references#CD011983-bbs2-0027" title="DolanK , MehrjerdiZA . Medication assisted treatment of opioid dependence: a review of the evidence. Australian National Council on Drugs2015. ">Dolan 2015</a>; <a href="./references#CD011983-bbs2-0032" title="GowingL , AliR , DunlopA , FarrellM , LintzerisN . National Guidelines for Medication‐Assisted Treatment of Opioid Dependence. Print ISBN: 978‐1‐74241‐944‐2; Online ISBN: 978‐1‐74241‐945‐92014. ">Gowing 2014</a>). A negative aspect of OST is that the medications used can be diverted. Diversion in this context encompasses both the sale of medications on the black market, and the unsanctioned use of medications, for example by accumulating doses and then using larger amounts than prescribed, or use by injection (<a href="./references#CD011983-bbs2-0037" title="LaranceB , DegenhardtL , LintzerisN , BellJ , WinstockA , DietzeP , et al. Post‐marketing surveillance of buprenorphine‐naloxone in Australia: diversion, injectionand adherence with supervised dosing. Drug Alcohol Dependence2011;1(118(2‐3)):265‐73. [doi: 10.1016/j.drugalcdep.2011.04.002.] ">Larance 2011</a>). Access to unsupervised or take‐away doses of medication is then a privilege that can be used to support contingency management approaches to treatment (<a href="./references#CD011983-bbs2-0022" title="BellJ . Pharmacologicalmaintenance treatments ofopiate addiction. British Journal of ClinicalPharmacology2014;77(2):253–63. [DOI: DOI:10.1111/bcp.12051] ">Bell 2014</a>; <a href="./references#CD011983-bbs2-0057" title="WHO2009 . Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. http://www.who.int/hiv/pub/idu/opioid/en/2009; Vol. ISBN 978 92 4 154754 3. ">WHO 2009</a>). </p> </section> <section id="CD011983-sec-0040"> <h3 class="title" id="CD011983-sec-0040">How the intervention might work</h3> <p>In the last two decades, OST diversion has been documented in countries all over the world and several studies have shown that a majority of methadone‐related deaths can be directly attributed to methadone diversion, often in patients not enrolled in any methadone maintenance treatment (MMT) programme (<a href="./references#CD011983-bbs2-0024" title="CiceroTJ . Diversion and abuse of methadone prescribed for pain management. JAMA2005;293:297–8. ">Cicero 2005</a>; <a href="./references#CD011983-bbs2-0051" title="SeymourA , BlackM , JayJ , CooperG , WeirC , OliverJ . The role of methadone in drug related deaths in the west of Scotland. Addiction2003;98:995‐1002. ">Seymour 2003</a>). </p> <p>To minimise diversion and misuse, it has been proposed that methadone be given under strict medical supervision (<a href="./references#CD011983-bbs2-0030" title="FountainJ , StrangJ , GossopM , FarrellM , GriffithsP . Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction2000;95:393–406. ">Fountain 2000</a>; <a href="./references#CD011983-bbs2-0055" title="VarenbutM , TeplinD , DaiterJ , RazB , WorsterA , Emadi‐KonjinP , et al. Tampering by office‐based methadone maintenance patients with methadone take home privileges: a pilot study. Harm Reduction Journal2007;4:5. ">Varenbut 2007</a>). Many countries have introduced treatment systems that require supervised dosing of OST (i.e. direct observation of methadone or buprenorphine consumption by the pharmacist or by the clinician), particularly for high‐risk patients, and supervised dosing is recommended in many clinical guidelines (<a href="./references#CD011983-bbs2-0057" title="WHO2009 . Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. http://www.who.int/hiv/pub/idu/opioid/en/2009; Vol. ISBN 978 92 4 154754 3. ">WHO 2009</a>). Supervised OST, often referred to as ‘supervised consumption’, is standard practice in many drug‐treatment centres, but it is expensive. Supervision ensures that patients take their medication as prescribed and prevents illicit drug diversion promoting stability and improving retention (<a href="./references#CD011983-bbs2-0057" title="WHO2009 . Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. http://www.who.int/hiv/pub/idu/opioid/en/2009; Vol. ISBN 978 92 4 154754 3. ">WHO 2009</a>). Both methadone and buprenorphine are sufficiently long acting to be taken once daily under supervision, if necessary. Regular contact through supervision may enhance treatment, but, on the other hand, prolonging supervision, may imply a lack of trust and may disadvantage patients as the need to attend daily for supervised dosing may interfere with employment opportunities and normal life activities. Hence, reducing the need for daily attendance for supervised dosing may improve patients' quality of life and facilitate rehabilitation and processes of reintegration into this community (<a href="./references#CD011983-bbs2-0045" title="RitterA , DiNatalieR . The relationship between take‐away methadone policies and methadone diversion. Drug and Alcohol Review2005;24(4):347–52. ">Ritter 2005</a>). In this context, qualitative studies of OST patients indicated that a flexible approach to supervision of dosing was appreciated (<a href="./references#CD011983-bbs2-0026" title="Dale‐PereraA , AlamF , BarkerP . Opioid‐dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out‐of‐treatment opioid users. Journal of Substance Use2015;20(5):354‐62. ">Dale‐Perera 2015</a>; <a href="./references#CD011983-bbs2-0043" title="NotleyCN , HollandR , NagarJ , MaskreyV , KouimtsidisC . Regaining control: the patient experience of supervised compared to unsupervised consumption in opiate substitution treatment. Drug and Alcohol Review2014;33(1):64‐70. [10.1111/ dar.12079] ">Notley 2013</a>). </p> </section> <section id="CD011983-sec-0041"> <h3 class="title" id="CD011983-sec-0041">Why it is important to do this review</h3> <p>The potential benefits to patients from less restrictive dosing strategies need to be balanced with the potential risks to the community from possible diversion of OST medications. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011983-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011983-sec-0042"></div> <p>The objective of this systematic review is to compare the effectiveness of opioid substitution treatment (OST) with supervised dosing relative to dispensing of medication for off‐site consumption. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011983-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011983-sec-0043"></div> <section id="CD011983-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011983-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs), and controlled clinical trials (CCTs) and prospective controlled cohort studies. The rationale for including study types other than RCTs was that it can be difficult to implement RCTs assessing supervised supply of OST medications. We did not expect to find many RCTs that answered our question. </p> </section> <section id="CD011983-sec-0046"> <h4 class="title">Types of participants</h4> <p>People "diagnosed as opioid dependent and receiving opioid substitution treatment with either buprenorphine or methadone". Patients with additional diagnosis such as alcoholism or in methadone‐maintenance schemes were also eligible. </p> </section> <section id="CD011983-sec-0047"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD011983-list-0001"> <li> <p>Experimental: supervised opioid substitution treatment (methadone, buprenorphine).</p> </li> <li> <p>Comparator: dispensing of medication to be consumed away from the dispensing point, usually without supervision. </p> </li> </ul> </p> </section> <section id="CD011983-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD011983-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011983-list-0002"> <li> <p>Retention in treatment defined as the number of participants who complete the study protocol (at any duration). </p> </li> <li> <p>Abstinence from unsanctioned opioid use (measured by urine drug screen or self‐report use). </p> </li> <li> <p>Diversion, defined as inappropriate use of medication by those for whom it has been prescribed, for example the selling or sharing of medication by patients to the illicit drug market. </p> </li> <li> <p>Frequency of unsanctioned opioid use at the end of the intervention period.</p> </li> </ul> </p> </section> <section id="CD011983-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011983-list-0003"> <li> <p>Adverse effects of medication (number of participants experiencing any adverse event).</p> </li> <li> <p>Mortality or serious adverse event.</p> </li> <li> <p>Severity of dependence as measured by validated scales e.g. Addiction Severity Index (ASI), Clinical Global Impression ‐ Severity scale (CGI‐S), Clinical Global Impression ‐ Observer scale (CGI‐O). </p> </li> <li> <p>Overdoses.</p> </li> <li> <p>Craving as measured by validated scales e.g. Brief Substance Craving Scale (BSCS), Visual Analogue Scale (VAS). </p> </li> <li> <p>Pain, assessed by validated scales such as the Brief Pain Inventory (<a href="./references#CD011983-bbs2-0025" title="CleelandCS . The Brief Pain Inventory. User Guide. Houston,Texas: The University of Texas, Anderson Cancer Center, 2009. ">Cleeland 2009</a>) and the McGill Pain Questionnaire (<a href="./references#CD011983-bbs2-0041" title="MelzackR . The McGill Pain Questionnaire: major properties and scoring methods. Pain1975;1(3):277‐99. ">Melzack 1975</a>) for prescribed opioid‐dependent people. </p> </li> <li> <p>Aberrant opioid‐related behaviours (e.g. seeing multiple doctors for extra opioid medication, lost medication, unauthorised dose escalations), for prescribed opioid‐dependent people. </p> </li> </ul> </p> </section> </section> </section> <section id="CD011983-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011983-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched the following bibliographic databases:</p> <p> <ul id="CD011983-list-0004"> <li> <p>the Cochrane Drugs and Alcohol Group's Specialised Register of Trials (on 15 April 2016); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2016, Issue 10, (April 2016)); </p> </li> <li> <p>Embase (Elsevier, Embase.com) (1974 to 15 April 2016);</p> </li> <li> <p>MEDLINE (EBSCO host) (1966 to 15 April 2016);</p> </li> <li> <p>Web of Science (1990 to 15 April 2016).</p> </li> </ul> </p> <p>The search strategy used for each database combined appropriate controlled vocabulary terms (as applicable) and free‐text terms relating to opioid use and supervised therapy. Details of the search strategies for all databases are shown in <a href="https://archie.cochrane.org/sections/documents/view?version=z1210031411159642847678868369817%26format=REVMAN#APP-01" target="_blank">Appendix 1</a>, <a href="https://archie.cochrane.org/sections/documents/view?version=z1210031411159642847678868369817%26format=REVMAN#APP-02" target="_blank">Appendix 2</a>, <a href="https://archie.cochrane.org/sections/documents/view?version=z1210031411159642847678868369817%26format=REVMAN#APP-03" target="_blank">Appendix 3</a>, and <a href="https://archie.cochrane.org/sections/documents/view?version=z1210031411159642847678868369817%26format=REVMAN#APP-04" target="_blank">Appendix 4</a>. We did not apply any filter on study design or language. </p> <p>We conducted additional searches for ongoing clinical trials on the following sites:</p> <p> <ul id="CD011983-list-0005"> <li> <p><a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a> (last searched 30 April 2016); </p> </li> <li> <p><a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>, International Clinical Trials Registry Platform (last searched 30 April 2016). </p> </li> </ul> </p> <p>We also searched relevant websites which are likely to contain evaluations of treatments for opioid dependence, such as: </p> <p> <ul id="CD011983-list-0006"> <li> <p>Substance Abuse and Mental Health Services Administration‐SAMHSA ( www.samhsa.gov/);</p> </li> <li> <p>Drug and Alcohol Findings (http://findings.org.uk/);</p> </li> <li> <p>National Institute of Drug Abuse (https://www.drugabuse.gov/).</p> </li> </ul> </p> </section> <section id="CD011983-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We searched the bibliographies of included studies to find additional studies and used the Web of Science (ISI Web of Knowledge, April 2016) to identify additional studies that had cited included studies. </p> <p>We contacted study investigators of relevant studies to request any details of any other known study. </p> </section> </section> <section id="CD011983-sec-0054"> <h3 class="title" id="CD011983-sec-0054">Data collection and analysis</h3> <section id="CD011983-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors (RS, SV) independently screened and evaluated all titles and abstracts (where available) identified by the literature search, in accordance with the described inclusion criteria (see <a href="#CD011983-sec-0044">Criteria for considering studies for this review</a>). We retrieved full‐text copies of papers judged to be potentially relevant by at least one author. The same review authors independently reviewed the full‐text articles for inclusion. Differences were resolved through discussion until consensus was reached. Multiple publications were collated and assessed as one study. </p> </section> <section id="CD011983-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>For trials that fulfilled inclusion criteria, two review authors (RS, SV) extracted data independently using a data extraction form. We considered information about study design, settings and number of study centres and location, characteristics of participants and interventions (type of drugs, dosage and frequency of supervised administration, additional co‐interventions), outcomes and times reported, length of follow‐up, funding and conflict of interest. We planned to extract both dichotomous and continuous outcome data, and details of the analysis (intention‐to‐treat or per‐protocol analysis). Any discrepancies between the data were resolved through discussion with the third review author. We transferred data into Review Manager software version 5.3. (<a href="./references#CD011983-bbs2-0044" title="Copenaghen: The Nordic Cochrane Centre. Review Manager (RevMan) Version 5.3. The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and checked for accuracy. </p> </section> <section id="CD011983-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (RS, SV) independently assessed the risk of bias of the included studies. We used the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011983-bbs2-0033" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>) to assess the risk of bias for RCTs based on seven standard criteria: adequate sequence generation; concealment of allocation; blinding of participants and providers, blinding of outcome assessor; adequately addressed incomplete outcome data; freedom from selective reporting; freedom from other risk of bias. Blinding of participants and providers and blinding of outcome assessor were assessed separately for objective outcomes (e.g. retention, use of substance of abuse measured by urine analysis) and subjective outcomes (e.g. patient self‐reported use of substance, adverse effects, diversion). We considered incomplete outcome data (avoidance of attrition bias) for all outcomes except for retention in treatment, which is the primary outcome measure in trials on the field of addiction. </p> <p>For observational studies, we included in the 'Risk of bias' table some additional criteria suggested by the Effective Practice and Organization of Care (<a href="./references#CD011983-bbs2-0028" title="Effective Practice and Organization of Care Cochrane Group. EPOC Resources for Cochrane Authors. http://epoc.cochrane.org/epoc‐specific‐resources‐review‐authors (accessed 22 February, 2016). ">EPOC 2016</a>) "Risk of bias" tool for non‐randomised studies. Specifically for cohort studies, we considered baseline outcome measurements, baseline characteristics, and protection against contamination. For a detailed description of the criteria used to assess risk of bias, see <a href="./appendices#CD011983-sec-0118">Appendix 5</a>. </p> <p>The first part of the tool involves describing what was reported to have happened in the study. The second part of the tool involves assigning a judgement relating to the risk of bias for that entry, in terms of low, high or unclear risk. We resolved any disagreements by discussion. </p> <section id="CD011983-sec-0058"> <h5 class="title">Grading of evidence</h5> <p>We assessed the overall quality of the evidence for the primary and secondary outcomes using the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. The GRADE Working Group developed a system for grading the quality of evidence that takes into account issues not only related to internal validity but also to external validity, such as directness of results (<a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD008969.pub3#CD008969-bbs2-0047" target="_blank">GRADE 2004</a>; <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD008969.pub3#CD008969-bbs2-0048" target="_blank">Guyatt 2008</a>; <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD008969.pub3#CD008969-bbs2-0049" target="_blank">Guyatt 2011</a>; <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD008969.pub3#CD008969-bbs2-0072" target="_blank">Schünemann 2006</a>). We prepared a 'Summary of findings' table to report the main findings of the review in a transparent and simple tabular format. In particular, the table provides key information concerning the quality of evidence, the magnitude of effect of the interventions examined, and the sum of available data for retention at the end of treatment (including all follow‐up periods), retention at three months of follow‐up,and any adverse serious events. </p> <p>The GRADE system uses the following criteria for assigning grades of evidence.</p> <p> <ul id="CD011983-list-0007"> <li> <p>High: further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p>Moderate: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low: any estimate of effect is very uncertain.</p> </li> </ul> </p> <p>Grading is decreased for the following reasons.</p> <p> <ul id="CD011983-list-0008"> <li> <p>Serious (‐1) or very serious (‐2) limitation to study quality.</p> </li> <li> <p>Important inconsistency (‐1).</p> </li> <li> <p>Some (‐1) or major (‐2) uncertainty about directness.</p> </li> <li> <p>Imprecise or sparse data (‐1).</p> </li> <li> <p>High probability of reporting bias (‐1).</p> </li> </ul> </p> <p>Grading is increased for the following reasons.</p> <p> <ul id="CD011983-list-0009"> <li> <p>Strong evidence of association ‐ significant risk ratio of &gt; 2 (0.5) based on consistent evidence from two or more observational studies, with no plausible confounders (+1). </p> </li> <li> <p>Very strong evidence of association ‐ significant risk ratio of &gt; 2 (&lt; 0.5) based on direct evidence with no major threats to validity (+2). </p> </li> <li> <p>Evidence of a dose‐response gradient (+1).</p> </li> <li> <p>All plausible confounders would have reduced the effect (+1).</p> </li> </ul> </p> </section> </section> <section id="CD011983-sec-0059"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, we presented results as risk ratios (RRs) with 95% confidence intervals (95% CIs). For continuous outcomes data, we planned to calculate the mean differences (MDs) with 95% CIs if studies used the same measurement scale. If studies used different scales we planned to calculate the standardised mean difference (SMD). </p> <p>We performed meta‐analyses according to the recommendations of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011983-bbs2-0033" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>). </p> </section> <section id="CD011983-sec-0060"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participants in the included studies. In the case of studies with multiple treatment arms, we planned to combine all relevant experimental intervention groups of the study into a single group, and to combine all relevant control intervention groups into a single control group (<a href="./references#CD011983-bbs2-0033" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>). This approach was used to prevent inappropriate double‐counting of individuals. </p> </section> <section id="CD011983-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered the clinical and methodological characteristics of the included studies to evaluate a clinically meaningful summary of data. We tested statistical heterogeneity in each meta‐analysis using the I² and Chi² statistics. We regarded heterogeneity as substantial if the I² was greater than 50%, or a P value was lower than &lt; 0.10 for the Chi² test for heterogeneity. Following the guidance in the <i>Cochrane Handbook for Systematic Reviews of Intervention</i> (<a href="./references#CD011983-bbs2-0033" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>), we distinguished the following values to denote not important, moderate, substantial, and considerable heterogeneity, respectively: 0% to 40%, 30% to 60%, 50% to 90%, and 75% to 100%. Had we found considerable levels of heterogeneity (i.e., ≥ 75%), we planned to explore possible reasons by visually inspecting the forest plot to identify studies that might be contributing to heterogeneity. </p> </section> <section id="CD011983-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not assess reporting biases using funnel plots for asymmetry as an indication of publication bias because the analyses that we were able to undertake included less than 10 studies. </p> </section> <section id="CD011983-sec-0063"> <h4 class="title">Data synthesis</h4> <p>Where data were available we carried out statistical analysis using the Review Manager software (RevMan 5.3). We combined outcome data from the individual trials through meta‐analysis where possible (comparability of intervention and outcomes between trials). We planned to pool data using a random‐effects model for all analyses because a certain degree of heterogeneity of interventions and outcomes (different duration and different follow‐up measures) was expected. Specifically, we used the Mantel‐Haenszel method for dichotomous data and planned to use the same method for continuous data. </p> <p>The results are presented as the average treatment effect with its 95% CI, and the estimates of Chi² and I² are reported. </p> <p>Where it was not possible to pool data or only one study was included in the comparison, we reported the outcomes in the text in a narrative way and discussed the results. </p> </section> <section id="CD011983-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct subgroup analyses for studies where the majority of participants were using street heroin compared to prescription opioids, but this was not possible because of the insufficient data available. </p> </section> <section id="CD011983-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analysis for primary outcomes by excluding trials with high risk for allocation concealment and sequence generation. This was unnecessary as none of the included studies were assessed as being at high risk for selection bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011983-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011983-sec-0066"></div> <section id="CD011983-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD011983-sec-0068"> <h4 class="title">Results of the search</h4> <p>Through bibliographic searches we identified 2171 records. After removing duplicates we screened 1651 reports and we excluded 1631 based on the title and abstract. We retrieved 20 articles for more detailed evaluation, 14 of which we excluded after reading the full text. The remaining six studies met all the inclusion criteria and were included in the review (see <a href="#CD011983-fig-0001">Figure 1</a>). No ongoing studies were identified. </p> <div class="figure" id="CD011983-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011983-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011983-sec-0069"> <h4 class="title">Included studies</h4> <p>Details of the individual studies are provided in the <a href="./references#CD011983-sec-0126" title="">Characteristics of included studies</a> tables. We included six studies of opioid‐dependent people receiving opioid substitution treatment (OST) with a total of 7999 participants, 7587 receiving methadone (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>), and 119 receiving buprenorphine–naloxone (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>). <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a> includes 293 participants in buprenorphine (Subutex®/Suboxone®) or methadone maintenance. </p> <p>Of the six included studies, four were randomised controlled trials (RCTs) (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>), and two had a prospective observational cohort study design (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>). The RCTs employed a simple randomisation procedure based on individual allocation to the intervention and control groups. In the observational studies, opioid users were recruited through interviews of all eligible patients referred to long‐term methadone treatment centres (<a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>), or from a national methadone treatment register (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>). The sample size ranged from 60 (<a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>, pilot study) to 6983 (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>) participants.<br/> <br/> All studies were conducted in high‐income countries: two in the UK (<a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>), one each from Ireland (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>), Australia (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>)<i>,</i> Italy (<a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>), and the USA (<a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). Two studies were single‐centre (<a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>); the remaining were multicentre trials (with three centres: <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; four centres: <a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; 12 centres: <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>). </p> <section id="CD011983-sec-0070"> <h5 class="title">Overview of study participants</h5> <p>Overall, the participants had a diagnosis of opioid dependence with a mean age of 35 years. The proportion of males was high, ranging from 68% (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>) to 83% (<a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>). Only one study, reported data on race, where the predominant (77%) of participants were African‐American (<a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). </p> <p>Participants were defined differently across the studies: in <a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>, opioid‐dependent participants, meeting the criteria for entry to maintenance treatment, were initiated on buprenorphine, usually on the day of presentation (day one). In <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a> and <a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>, community centres recruited all eligible patients referred for long‐term methadone treatment. In the study conducted by <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>, participants were eligible if they had confirmed opioid dependence and had been managed with supervised methadone for three months (with a two‐week ‘window’ before or after the three‐month point). In <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>, eligible clients with confirmed symptoms and toxicological evidence of opioid dependency commenced maintenance therapy with methadone/buprenorphine, and in <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>, individuals being placed on a waiting‐list for publicly‐subsidised treatment availability at one of two methadone treatment programmes (MTPs) were recruited. None of the studies included participants with prescription opioids dependence. </p> <p>Participants with psychiatric co‐morbidities were included only in one study (<a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>). </p> </section> <section id="CD011983-sec-0071"> <h5 class="title">Treatment regimens or Interventions</h5> <p>All studies reported the setting of interventions. Five studies delivered the interventions in an outpatient setting (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>), and one trial was in a community pharmacy (<a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>). The mean duration of the treatments in five studies was 5.5 months (range three to 12 months); <a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a> had a follow‐up of 72 months. </p> <p>Of the included studies, four studies allocated participants to one of two groups, the intervention (supervision consumption of opioid maintenance treatment) and a control group (no supervision) (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). Two studies allocated participants to one of three groups, two of which were control groups comprising slight variations of the same programme in terms of intensity or modality (<a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>). </p> <p>Administration of methadone under supervision condition was studied in four studies (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>, <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a> tested a supervised daily consumption, contingent take‐home incentives and a non‐contingent take‐home in three groups of heroin‐addicted patients attending different methadone maintenance treatment (MMT) programmes. </p> <p><a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a> considered supervised treatment with different intensity: a ‘twice weekly supervision’ scheme, where the pharmacist dispensed their medication daily, but supervision was on only two days per week; a "daily supervised consumption", where the pharmacist dispensed the medication to be swallowed under their supervision; "no supervision" with medication collected daily. </p> <p><a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a> assigned participants to methadone combined with psychosocial intervention of different intensities (emergency or routine counselling). Opioid substitution therapy (OST) with methadone or buprenorphine (Subutex®/Suboxone®) were used in <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>. </p> <p><a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a> randomly assigned all participants to medication with regular attendance at drug‐treatment centres (observed dosing), or picking up medication once per week, for administration at home (unobserved dosing). </p> </section> </section> <section id="CD011983-sec-0072"> <h4 class="title">Excluded studies</h4> <p>We excluded 14 studies (see table of <a href="./references#CD011983-sec-0127" title="">Characteristics of excluded studies</a>.The main reasons for exclusion were the type of interventions (<a href="./references#CD011983-bbs2-0007" title="AmassL , KamienJB , MikulichSK . Thrice‐weekly supervised dosing with the combination buprenorphine‐naloxone tablet is preferred to daily supervised dosing by opioid‐dependent humans. Drug and Alcohol Dependence2001;61(2):173‐81. ">Amass 2001</a>; <a href="./references#CD011983-bbs2-0008" title="AuriacombeM , FatseasM , DubernetJ , DaulouedeJP , TignolJ . French field experience with buprenorphine. American Journal on Addiction2004;13(S1):17‐28. ">Auriacombe 2004</a>; <a href="./references#CD011983-bbs2-0010" title="CarrieriPM , MichelL , LionsC , CohenJ , VrayM , MoraM , et al. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). PLoS One2014;9(11):e112328. ">Carrieri 2014</a>; <a href="./references#CD011983-bbs2-0011" title="GroshkovaT , MetrebianN , HallamC , CharlesV , MartinA , ForzisiL , et al. Treatment expectations and satisfaction of treatment‐refractory opioid‐dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug and Alcohol Review2013;32(6):566‐73. MetrebianN , GroshkovaT , HellierJ , CharlesV , MartinA , ForzisiL , et al. Drug use, health and social outcomes of hard‐to‐treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Addiction2015;110(3):479‐90. [DOI: 10.1111/add.12748] ">Groshkova 2013</a>; <a href="./references#CD011983-bbs2-0012" title="HaasenC , VertheinU , DegkwitzP , BergerJ , KrauszM , NaberD . Heroin‐assisted treatment for opioid dependence: randomised controlled trial. British Journal of Psychiatry : the journal of mental science2007;191(1):55‐62. ">Haasen 2007</a>; <a href="./references#CD011983-bbs2-0013" title="HutchinsonSJ , TaylorA , GruerL , BarrC , MillsC , ElliottL , et al. One‐year follow‐up of opiate injectors treated with oral methadone in a GP‐centred programme. Addiction (Abingdon, England)2000;95(7):1055‐68. ">Hutchinson 2000</a>; <a href="./references#CD011983-bbs2-0014" title="KakkoJ , SvanborgKD , KreekMJ , HeiligM . 1‐year retention and social function after buprenorphine‐assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo‐controlled trial. Lancet2003;361(9358):662‐8. ">Kakko 2003</a>; <a href="./references#CD011983-bbs2-0015" title="KrookAL , BrorsO , DahlbergJ , GrouffK , MagnusP , RoysambE , et al. A placebo‐controlled study of high dose buprenorphine in opiate dependents waiting for medication‐assisted rehabilitation in Oslo, Norway. Addiction (Abingdon, England)2002;97(5):533‐42. ">Krook 2002</a>; <a href="./references#CD011983-bbs2-0017" title="LintzerisN , LeungSY , DunlopAJ , LaranceB , WhiteN , RivasGR , et al. A randomised controlled trial of sublingual buprenorphine‐naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence2013;131(1‐2):119‐26. ">Lintzeris 2013</a>; <a href="./references#CD011983-bbs2-0018" title="StrangJ , MetrebianN , LintzerisN , PottsL , CarnwathT , MayetS , et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet2010;375(9729):1885‐95. ">Strang 2010</a>; <a href="./references#CD011983-bbs2-0019" title="SuzukiJ , MatthewsML , BrickD , NguyenMT , WasanAD , JamisonRN , et al. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid‐dependent patients and patients with chronic pain using opioids nonmedically. Journal of Opioid Management2014;10(3):159‐68. ">Suzuki 2014</a>; <a href="./references#CD011983-bbs2-0020" title="van denBrinkW , HendriksVM , BlankenP , KoeterMW , vanZwietenBJ , vanReeJM . Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ (Clinical research ed)2003;327(7410):310. ">van den Brink 2003</a>). One study was excluded because it was a protocol without any results (<a href="./references#CD011983-bbs2-0016" title="LintzerisN , StrangJ , MetrebianN , ByfordS , HallamC , LeeS , et al. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduction Journal2006;3:28. ">Lintzeris 2006</a>). In addition, the study <a href="./references#CD011983-bbs2-0009" title="BellJR , RyanA , MutchC , BateyR , ReaF . Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: Follow‐up of a randomised trial. Drug and Alcohol Dependence2008;96:183–6. ">Bell 2008</a> was excluded as it is a an open‐label extension study focused on only a selected sample of patients recruited from <a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>. </p> </section> </section> <section id="CD011983-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias was generally moderate across studies with some domains of the 'Risk of bias' assessment tool being satisfied for the majority of studies; (<a href="#CD011983-fig-0002">Figure 2</a>). We have summarised the results of the assessments for each study in <a href="#CD011983-fig-0003">Figure 3</a>, and in the following sections. </p> <div class="figure" id="CD011983-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD011983-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011983-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD011983-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD011983-sec-0074"> <h4 class="title">Allocation</h4> <section id="CD011983-sec-0075"> <h5 class="title">Random sequence generation</h5> <p>Four studies (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>) were judged at low risk of selection bias because they used a computer‐generated randomisation sequence to allocate adults to the experimental and control groups. Two studies were non‐randomised and assessed as having a high risk for selection bias (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>). </p> </section> <section id="CD011983-sec-0076"> <h5 class="title">Allocation concealment</h5> <p>Three studies (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>) were judged at low risk of selection bias because researchers used an adequate method for allocation concealment. We judged <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a> to have an unclear risk because investigators did not clearly report the method used for allocation concealment. Two studies were judged at high risk of bias (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>) because the study design was non‐randomised. </p> </section> </section> <section id="CD011983-sec-0077"> <h4 class="title">Blinding</h4> <section id="CD011983-sec-0078"> <h5 class="title">Performance bias</h5> <section id="CD011983-sec-0079"> <h6 class="title">Objective outcomes</h6> <p>The nature of the intervention made blinding of participants receiving the intervention and providers delivering the intervention impossible. For objective outcomes, we classified all studies as having a low risk of bias because we judged that they were not likely to be influenced by lack of blinding. </p> </section> <section id="CD011983-sec-0080"> <h6 class="title">Subjective outcomes</h6> <p>Participants and personnel were not blinded in five of the studies for these kind of interventions (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>), so we judged them to be at high risk of bias. One study (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>) was judged at low risk of bias because it did not consider any subjective outcomes. </p> </section> </section> <section id="CD011983-sec-0081"> <h5 class="title">Detection bias</h5> <section id="CD011983-sec-0082"> <h6 class="title">Objective outcomes</h6> <p>We rated five studies as having a low risk of bias for blinding of outcome assessment (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>) and one at high risk of bias (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>). </p> </section> <section id="CD011983-sec-0083"> <h6 class="title">Subjective outcomes</h6> <p>Five studies were judged at high risk of bias because the authors declared unblinded assessment at each follow up (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). <a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a> did not consider subjective outcomes. </p> </section> </section> </section> <section id="CD011983-sec-0084"> <h4 class="title">Incomplete outcome data</h4> <p>All four RCTs performed an intention‐to treat analysis. When studies reported missing outcome data, they were balanced in numbers across intervention and control groups, with similar reasons. We classified all studies as low risk of bias. In the <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a> study, five participants withdrew from the study and therefore it was assessed as being at low risk of bias. </p> </section> <section id="CD011983-sec-0085"> <h4 class="title">Selective reporting</h4> <p>Published trial registration information was available for only one study (<a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>). However, for all studies, we found all the outcomes listed in the 'Methods' section reported in the 'Results' section; so we judged all five studies as having low risk of bias (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>; <a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>; <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). </p> </section> <section id="CD011983-sec-0086"> <h4 class="title">Other potential sources of bias</h4> <p>We did not find other obvious sources of bias. We classified four studies as having a low risk of other bias (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>, <a href="./references#CD011983-bbs2-0004" title="HollandR , MathesonC , AnthonyG , RobertsK , PriyardarshiS , MacraeA , et al. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review2012;31(4):483‐91. ">Holland 2012</a>; <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>; <a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>). All included trials reported sufficient data for baseline characteristics in the intervention and control group to be judged comparable. In <a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>, the groups differed with respect to gender, criminal convictions, and alcohol use; we judged the study as having a low risk of bias because the authors fully adjusted all analyses for each potential confounders. </p> <p>The two observational studies included in the review, due to the study design, had a potential source of bias related to selection of participants and contamination of interventions. To address these bias, different measures were taken to reduce differences among the three recruiting centres and a standardised patient‐recruitment protocol was used in <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>. Moreover, the analysis were adjusted for possible confounders (gender and age) (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>; <a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>) and hence both were scored as having a low risk of potential bias. </p> </section> </section> <section id="CD011983-sec-0087"> <h3 class="title" id="CD011983-sec-0087">Effects of interventions</h3> <p>See: <a href="./full#CD011983-tbl-0001"><b>Summary of findings for the main comparison</b> Supervised dosing with a long‐acting medication compared to unsupervised consumption for opioid dependence</a> </p> <section id="CD011983-sec-0088"> <h4 class="title">Comparison: Supervised dosing vs unsupervised</h4> <p><i><b>See</b> </i><a href="./full#CD011983-tbl-0001">summary of findings Table for the main comparison</a> </p> <section id="CD011983-sec-0089"> <h5 class="title">Primary outcomes</h5> <section id="CD011983-sec-0090"> <h6 class="title">Retention</h6> <p>There was no significant difference in retention rate at any duration of treatment (three to 12 months) in the pooled data of four studies where participants received supervised treatment and the control group received unsupervised therapies (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.88 to 1.12; four studies, n = 716), <i>see</i><a href="./references#CD011983-fig-0004" title="">Analysis 1.1</a>. </p> <p>There was no important statistical heterogeneity in the meta‐analysis:Chi² = 4.03, df = 3 (P = 0.26); I² = 26%.The included period of duration of intervention with the most consistently available data across studies ranged between three and 12 months. </p> <p>Because of differences in duration of treatment, we conducted a separate analysis of the studies that reported data on retention assessed at three months (end of treatment). The pooled estimates across these studies yielded no difference between supervised and unsupervised therapy (RR 0.94, 95% CI 0.84 to 1.05; three studies, n = 472) <i>see</i><a href="./references#CD011983-fig-0005" title="">Analysis 1.2</a>., with no heterogeneity (I<sup>2</sup> = 0%). </p> <p>Data from observational study not included in meta analysis (<a href="./references#CD011983-bbs2-0003" title="GerraG , SaenzE , BusseA , MaremmaniI , CiccocioppoR , ZaimovicA , et al. Supervised daily consumption, contingent take‐home incentive and non‐contingent take‐home in methadone maintenance. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2011;35(2):483‐9. ">Gerra 2011</a>) reported no significant difference in retention between groups (RR 0.94, 95% CI 0.77 to 1.14; n = 300). </p> </section> <section id="CD011983-sec-0091"> <h6 class="title">Abstinence end of treatment (point abstinence)</h6> <p>One study (<a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>) found no difference between supervised and no supervised therapy in self‐reported heroin use at three months (67% versus 60%, P = 0.33; n = 293). </p> </section> </section> <section id="CD011983-sec-0092"> <h5 class="title">Abstinence end of treatment (continuous abstinence)</h5> <p>No studies assessed this outcome.</p> <section id="CD011983-sec-0093"> <h6 class="title">Diversion</h6> <p>One study (<a href="./references#CD011983-bbs2-0005" title="HollandR , MaskreyV , SwiftL , NotleyC , RobinsonA , NagarJ , et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction (Abingdon, England)2014;109(4):596‐607. ">Holland 2014</a>) found that a total of 5% respondents in the supervised group and 2% in the unsupervised group reported that "they had let another person have their drug", but it is not clear if the data referred to diversion. </p> <p><b>Days of unsanctioned opioid use (end of treatment)</b> </p> <p>No studies assessed this outcome.</p> </section> <section id="CD011983-sec-0094"> <h6 class="title">Secondary outcomes</h6> </section> <section id="CD011983-sec-0095"> <h6 class="title">Serious adverse events</h6> <p>Two trials (<a href="./references#CD011983-bbs2-0001" title="BellJ , ShanahanM , MutchC , ReaF , RyanA , BateyR , et al. A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine‐naloxone for heroin dependence. Addiction (Abingdon, England)2007;102(12):1899‐907. ">Bell 2007</a>;<a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>) reported the number of serious adverse events requiring hospitalisation such as accident, cardiovascular, respiratory, gastrointestinal diseases, urinary tract infection. Pooling these data no significant difference was found (RR 0.63, 95% CI 0.10 to 3.86, two studies, n = 363);<i>see</i><a href="./references#CD011983-fig-0005" title="">Analysis 1.2</a>. with a high heterogeneity (Chi² =63%). </p> </section> <section id="CD011983-sec-0096"> <h6 class="title">Overdoses</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011983-sec-0097"> <h6 class="title">Mortality</h6> <p><a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a> reported in the supervised group one death from gastric haemorrhage at day 304 post‐enrolment, and one death from pneumonia at day 334 post‐enrolment. </p> <p>One cohort study (<a href="./references#CD011983-bbs2-0002" title="CousinsG , BolandF , CourtneyB , BarryJ , LyonsS , FaheyT . Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study. Addiction2016;111(1):73‐82. ">Cousins 2016</a>) with data from 6983 participants and six years of follow‐up reported data on drug‐related mortality and all‐cause mortality. During follow‐up, 31 participants in the supervised group and 47 in the control group died for drug‐related effects but this was unrelated to regular supervised methadone consumption (mortality rate ratio = 0.76, 95 CI% = 0.32 to 1.80). All‐cause mortality was lower in those with regular supervision (crude mortality rate 0.60 versus 0.81 per 100 person‐years), although after adjustment insufficient evidence existed to suggest that regular supervision was protective (mortality rate ratio = 1.23, 95% CI = 0.67 to 2.27). </p> </section> <section id="CD011983-sec-0098"> <h6 class="title">Severity of dependence (Addiction Severity Index (ASI), Clinical Global Impression ‐ Severity scale (CGI) etc) </h6> <p>One study (<a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>) with 244 participants found no significant difference for the ASI composite scores (P &gt; 0.05). </p> </section> <section id="CD011983-sec-0099"> <h6 class="title">Craving (BSCS score, VAS etc)</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011983-sec-0100"> <h6 class="title">Pain</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011983-sec-0101"> <h6 class="title">Aberrant opioid related behaviours</h6> <p>No studies assessed this outcome.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011983-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011983-sec-0102"></div> <section id="CD011983-sec-0103"> <h3 class="title" id="CD011983-sec-0103">Summary of main results</h3> <p>This review has examined the published evidence comparing supervised versus unsupervised consumption of opiate substitution treatment. We identified six studies, four were randomised controlled trials (RCTs) and two were cohort studies, with a total of 7999 participants. Methadone or buprenorphine under medical supervision were used. The risk of bias was generally moderate across trials. Evidence on all the primary and secondary outcomes was considered limited: only one study considered the point abstinence at end of treatment, one study investigated the diversion and the severity of dependence. Moreover, effects on drug‐related mortality were inconclusive (only one study reported this outcome). None of the studies assessed continuous abstinence at the end of treatment, days of unsanctioned opioid use, overdose, craving, pain and aberrant opioid‐related behaviours. This scarcity of data meant that we could perform a limited number of meta‐analyses. Across all of the included studies, all reported retention outcome but we did not find a difference between supervised treatment and unsupervised treatment in increased retention rate,<i>low‐quality of evidence</i> . Stratifying for the duration of treatment, no significant results were found at three months, <i>low‐quality of evidence.</i> For the outcome adverse events, meta‐analysis of two studies found no increase or decrease for any serious adverse events in those exposed to supervised therapy, <i>very low‐quality of evidence</i>. </p> </section> <section id="CD011983-sec-0104"> <h3 class="title" id="CD011983-sec-0104">Overall completeness and applicability of evidence</h3> <p>The strength of the evidence available is limited by the small number of studies, some of them were quite small, and by the variability of outcome measures utilised, which limits the meta‐analysis and the conclusions. Most of the included studies did not assess some of secondary outcomes prespecified in the review. </p> <p>For example, based on the available data, it is not possible to draw any conclusions regarding the risk of diversion of opioid substitution treatment (OST) for unauthorised use in the treatment and in control group, while maintaining access to OST. </p> <p>An important weakness of the review is the applicability of findings. First at all, most included studies were conducted with predominantly in men, stable opioid‐dependent participants receiving OST in specialised opioid‐dependence treatment programmes, and it is unclear whether findings are generalisable to other populations, for example those dependent upon prescription opioids, and women. Secondly, five of the six studies were conducted in countries where opioid substitution is widely available. Stronger evidence would be gained from replicating trials on people dependent on opioids living in other settings. </p> <p>Apart from one study (<a href="./references#CD011983-bbs2-0006" title="SchwartzRP , KellySM , O'GradyKE , GandhiD , JaffeJH . Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings. Addiction (Abingdon, England)2012;107(5):943‐52. ">Schwartz 2012</a>), we did not identify any studies combining OST and psychosocial measures such as supportive counselling, psychotherapy, assistance with social needs such as housing, employment, education, welfare and legal problems. Authors of one systematic review reported that individual or group counselling or psychosocial support may improve abstinence rates in comparison to pharmacotherapy alone (<a href="./references#CD011983-bbs2-0021" title="AmatoL , MinozziS , DavoliM , VecchiS . Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD004147.pub4] ">Amato 2011</a>). </p> </section> <section id="CD011983-sec-0105"> <h3 class="title" id="CD011983-sec-0105">Quality of the evidence</h3> <p>The major limitation of the review was the small number of studies included, two of which used an observational study design and therefore at high risk of bias. Four of the six included studies were RCTs with low risk of bias, although blinding of participants and clinicians involved in the supervised consumption of opiate substitution treatment was impossible. Thus, we cannot rule out performance bias. Our 'Risk of bias' estimates show that a main limitation is due to the high risk of detection bias (subjective outcomes) in some studies. Using GRADE, the quality of evidence was downgraded to low and very low for all outcomes (see <a href="./full#CD011983-tbl-0001">summary of findings Table for the main comparison</a>) so that further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p>We found high heterogeneity when we combined data for serious adverse events outcomes (<i>see</i><a href="./references#CD011983-fig-0005" title="">Analysis 1.2</a>), reducing the confidence that can be placed in these results. No heterogeneity resulted for the other analyses. </p> </section> <section id="CD011983-sec-0106"> <h3 class="title" id="CD011983-sec-0106">Potential biases in the review process</h3> <p>We minimised potential publication biases in the review process by searching different databases such as the Cochrane Drug and Alcohol Group's Specialised Register, MEDLINE and Embase with no limits on language or year of publication, but we only identified a small number of studies. We planned to assess the publication bias using the funnel plots but, in line with recommendations, we did not perform statistical tests of asymmetry due to the small number of trials. Alternatively, we investigated publication bias by searching for non‐published data via the website of international organisations and registers of clinical trials. </p> </section> <section id="CD011983-sec-0107"> <h3 class="title" id="CD011983-sec-0107">Agreements and disagreements with other studies or reviews</h3> <p>In this review we summarised for the first time the evidence from all randomised controlled trials that have experimented a supervised strategy in the intervention for patients with opioid dependence. To our best knowledge, no systematic review on the efficacy of supervised consumption of opiate substitution has been published. </p> <p>Clinical guidelines published in 2007 and 2009 (<a href="./references#CD011983-bbs2-0042" title="NICE . Technology appraisal guidance‐Methadone and buprenorphine for the management of opioid dependence 2007. https://www.nice.org.uk/guidance/ta114. ">NICE 2007</a>; <a href="./references#CD011983-bbs2-0057" title="WHO2009 . Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. http://www.who.int/hiv/pub/idu/opioid/en/2009; Vol. ISBN 978 92 4 154754 3. ">WHO 2009</a>) recommend a period of supervised consumption of opioid medicines in the early phase of treatment, although the quality of evidence was considered low on the base of the available observational studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011983-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/urn:x-wiley:14651858:media:CD011983:CD011983-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_t/tCD011983-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011983-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011983-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/urn:x-wiley:14651858:media:CD011983:CD011983-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_t/tCD011983-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD011983-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011983-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/urn:x-wiley:14651858:media:CD011983:CD011983-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_t/tCD011983-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD011983-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011983-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/urn:x-wiley:14651858:media:CD011983:CD011983-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_t/tCD011983-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 supervised vs unsupervised, Outcome 1 Retention." data-id="CD011983-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 supervised vs unsupervised, Outcome 1 Retention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/references#CD011983-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011983-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/urn:x-wiley:14651858:media:CD011983:CD011983-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_t/tCD011983-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 supervised vs unsupervised, Outcome 2 Adverse serious events (any)." data-id="CD011983-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 supervised vs unsupervised, Outcome 2 Adverse serious events (any).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/references#CD011983-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/media/CDSR/CD011983/image_n/nCD011983-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011983-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supervised dosing with a long‐acting medication compared to unsupervised consumption for opioid dependence</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Supervised versus unsupervised dosing</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with opioid dependence<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> supervised dosing with a long‐acting medication<br/> <b>Comparison:</b> unsupervised consumption </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Unsupervised</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Supervised</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Retention ‐ retention at the end of treatment</b> <br/> (number of participants)<br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.99</b> <br/> (0.88 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>716<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>634 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>628 per 1000</b> <br/> (558 to 710) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>653 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>646 per 1000</b> <br/> (575 to 731) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Retention ‐ retention at 3 months</b> <br/> (number of participants)<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.94</b> <br/> (0.84 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>472<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>707 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>664 per 1000</b> <br/> (594 to 742) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>737 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>693 per 1000</b> <br/> (619 to 774) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse serious events (any)</b> <br/> (number of participants)<br/> Follow‐up: mean 7.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.63</b> <br/> (0.10 to 3.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>363<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> <br/> (8 to 298) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (8 to 309) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Abstinence from unsanctioned opioid use</b> <br/> (number of participants with urine drug screen or self‐report use)<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>293<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>No difference between supervised and no supervised therapy in self‐reported heroin use at 3 months (67% <i>vs</i> 60%, P = 0.33) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Diversion (</b>number of participants)<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>293<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5% respondents in the supervised group and 2% in the unsupervised group reported that "they had let another person have their drug", but it is not clear if the data referred to diversion. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency of unsanctioned opioid use at the end of the intervention (number of days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality ‐</b> <br/> (number of participants) </p> <p>Follow‐up: mean 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>230<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It was reported one death from gastric haemorrhage at day 304 post‐enrolment, and one death from pneumonia at day 334 post‐enrolment. </p> <p>In one cohort study (6983 participants), the mortality rate ratio was unrelated to regular supervised methadone consumption. All‐cause mortality was lower in those with regular supervision (crude mortality rate 0.60 versus 0.81 per 100 person‐years), although after adjustment insufficient evidence existed to suggest that regular supervision was protective (mortality rate ratio = 1.23, 95% CI = 0.67–2.27). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded of two levels because all studies were at high risk for performance bias, one at high risk of detection bias and one at unclear risk for selection bias<br/> <sup>2</sup> Downgraded of two levels because all studies were at high risk for performance bias, one at high risk of detection bias and one at unclear risk for selection bias<br/> <sup>3</sup> Downgraded of two levels because two studies at high risk for performance and detection bias<br/> <sup>4</sup> Downgraded of two levels because OIS not met<br/> <sup>5</sup> Downgraded of two levels because the study was at high risk for performance and detection bias </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supervised dosing with a long‐acting medication compared to unsupervised consumption for opioid dependence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/full#CD011983-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011983-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">supervised vs unsupervised</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 retention at any duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.88, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 retention at 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.84, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adverse serious events (any) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.10, 3.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">supervised vs unsupervised</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011983.pub2/references#CD011983-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011983.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011983-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011983-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011983-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011983-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011983-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD011983-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011983-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011983-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011983\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011983\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011983\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011983\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011983\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011983.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011983.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011983.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011983.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011983.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718191871"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011983.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718191875"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011983.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dca522b9ff3fd',t:'MTc0MDcxODE5Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 